STRATEC Biomedical AG
Deschisă
17.48 3.43
Rezumat
Modificarea prețului
24h
Minim
16.68
Maxim
17.74
Venit | 2.6M -1.7M |
|---|---|
Vânzări | -22M 53M |
P/E Medie Sector | 14.63 30.136 |
EPS | -0.357 |
Randament dividend | 3.3 |
Marjă de profit | -3.206 |
Angajați | 1,395 |
EBITDA | -6.7M 4.1M |
Recomandări | Cumpărare |
|---|---|
Prognoză pe 12 luni | +55.9% upside |
Randament dividend Medie Sector | 3.30% 3.27% |
|---|---|
Următoarele câștiguri | 14 aug. 2026 |
Capitalizare de piață | 6.8M 221M |
|---|---|
Deschiderea anterioară | 14.05 |
Închiderea anterioară | 17.48 |
STRATEC Biomedical AG Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Despre STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
